Presumed sertraline maculopathy

Acta Ophthalmologica Scandinavica

Volumn 79, Issue 4, 2001, Pages 428-430

  Sener E C ^a   Kiratli, H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Maculopathy; Retinal pigment epithelium; Sertraline; Toxicity

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; COLOR VISION TEST; DEPRESSION; DRUG WITHDRAWAL; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EYE FUNDUS; FAMILY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; PERIMETRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULOPATHY; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULA LUTEA; MIDDLE AGED; RETINAL DISEASES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; VISUAL ACUITY;

EID: 0034917472     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2001.079004428.x     Document Type: Article

References (7)

1. Anisocoria associated with selective serotonin reuptake inhibitors
2. Visual hallucinations associated with fluoxetine and sertraline
3. Butterfly shaped pigment dystrophy of the fovea
4. Vitelliform macular dystrophy and butterfly-shaped epithelial dystrophy: A continuum?
5. Toxic optic neuropathy after concomitant use of melatonin, zoloft and a high-protein diet